the safety and tolerance data of the preliminary results of a randomised , parallel group , multicentre trial of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex ( apsac ) in patients with myocardial infarction are presented .
C0078956
anisoylated plasminogen streptokinase activator complex
C0027051
myocardial infarction